Evidence map›Paper›PMID 33607015›Full record

SynthesisThe Lancet. Global health2021

Association between vision impairment and mortality: a systematic review and meta-analysis.

Joshua R Ehrlich, Jacqueline Ramke, David Macleod, Helen Burn, Chan Ning Lee, Justine H Zhang, William Waldock, Bonnielin K Swenor, Iris Gordon, Nathan Congdon and 2 more

Open access · goldAbstract readComparative StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Lancet. Global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 7 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 7 syntheses or guidelines pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 3 countries.

Joshua R EhrlichDepartment of Ophthalmology and Visual Sciences, and Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA. Electronic address: joshre@med.umich.edu.
Jacqueline RamkeInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK; School of Optometry and Vision Science, University of Auckland, Auckland, New Zealand.
David MacleodMRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK; International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK.
Helen BurnDepartment of Ophthalmology, Stoke Mandeville Hospital, Aylesbury, UK.
Chan Ning LeeInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK; St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK.
Justine H ZhangInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK; Manchester Royal Eye Hospital, Manchester, UK.
William WaldockUniversity of Cambridge School of Medicine, Cambridge, UK.
Bonnielin K SwenorWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Iris GordonInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK.
Nathan CongdonQueen's University Belfast, Belfast, UK; Zhongshan Ophthalmic Center, Guangzhou, China.
Matthew BurtonInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK; Moorfields Eye Hospital, London, UK.
Jennifer R EvansInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBJohns Hopkins Medicine · USMoorfields Eye Hospital · GBQueen's University Belfast · GBStoke Mandeville Hospital · GBUniversity of Cambridge · GBUniversity of Liverpool · GBUniversity of Michigan–Ann Arbor · US

Funding

Addressing Low Vision due to Severe Peripheral Field Loss: Development and Validation of a Patient-Centered Outcome MeasureK23EY027848 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI EHRLICH, JOSHUA ROBERT · 2017 to 2021
$1.2M
Vision Loss and Cognition: Testing the sensory consequence hypothesisK01AG052640 · NIA · JOHNS HOPKINS UNIVERSITY · PI SWENOR, BONNIELIN · 2017 to 2021
$834k
Department of HealthMedical Research Council MR/R010161/1NEI NIH HHS K23 EY027848NIA NIH HHS K01 AG052640Wellcome Trust 207472/Z/17/Z
6 · The paper itself

Abstract

backgroundThe number of individuals with vision impairment worldwide is increasing because of an ageing population. We aimed to systematically identify studies describing the association between vision impairment and mortality, and to assess the association between vision impairment and all-cause mortality.

methodsFor this systematic review and meta-analysis, we searched MEDLINE (Ovid), Embase, and Global Health database on Feb 1, 2020, for studies published in English between database inception and Feb 1, 2020. We included prospective and retrospective cohort studies that measured the association between vision impairment and all-cause mortality in people aged 40 years or older who were followed up for 1 year or more. In a protocol amendment, we also included randomised controlled trials that met the same criteria as for cohort studies, in which the association between visual impairment and mortality was independent of the study intervention. Studies that did not report age-adjusted mortality data, or that focused only on populations with specific health conditions were excluded. Two reviewers independently assessed study eligibility, extracted the data, and assessed risk of bias. We graded the overall certainty of the evidence using the Grading of Recommendations, Assessment, Development and Evaluations framework. We did a random-effects meta-analysis to calculate pooled maximally adjusted hazard ratios (HRs) for all-cause mortality for individuals with a visual acuity of <6/12 versus those with ≥6/12; <6/18 versus those with ≥6/18; <6/60 versus those with ≥6/18; and <6/60 versus those with ≥6/60.

findingsOur searches identified 3845 articles, of which 28 studies, representing 30 cohorts (446 088 participants) from 12 countries, were included in the systematic review. The meta-analysis included 17 studies, representing 18 cohorts (47 998 participants). There was variability in the methods used to assess and report vision impairment. Pooled HRs for all-cause mortality were 1·29 (95% CI 1·20-1·39) for visual acuity <6/12 versus ≥6/12, with low heterogeneity between studies (n=15; τ

interpretationThe hazard for all-cause mortality was higher in people with vision impairment compared with those that had normal vision or mild vision impairment, and the magnitude of this effect increased with more severe vision impairment. These findings have implications for promoting healthy longevity and achieving the Sustainable Development Goals.

fundingWellcome Trust, Commonwealth Scholarship Commission, National Institutes of Health, Research to Prevent Blindness, the Queen Elizabeth Diamond Jubilee Trust, Moorfields Eye Charity, National Institute for Health Research, Moorfields Biomedical Research Centre, Sightsavers, the Fred Hollows Foundation, the Seva Foundation, the British Council for the Prevention of Blindness, and Christian Blind Mission.

Indexed as

MortalityGlobal HealthHumansRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsSeverity of Illness IndexVision Disorders

Identifiers

PMID33607015
PMCPMC7966688
OpenAlexW3132436110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.